One year from Pfizer vaccine news, some unlikely market outcomes

By Danilo Masoni and Saikat Chatterjee

LONDON (Reuters) – It is exactly a year since Pfizer’s announcement of a breakthrough on its experimental COVID-19 vaccine but from emerging markets to airline stocks, many of the trades that were expected to benefit…

Click here to view the original article.